Y-31

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameY-31
Drug Alias NamemTOR inhibitor (Shanghai Haihe/Shanghai Institute of Materia Medica)Y-31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShangHai HaiHe Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShangHai HaiHe Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A